Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference

Wednesday, February 4, 2009 General News J E 4
SEATTLE, Feb. 3 Dendreon Corporation(Nasdaq: DNDN) today announced that management will present a company updateat the Eleventh Annual BIO CEO & Investor Conference in New York City, onTuesday, February 10, 2009 at 1:45 p.m. ET.

A live audio webcast of the presentation will be accessible through theInvestor Relations section of the Dendreon website, you are unable to listen to the live webcast, it will be archived on thesite following the presentation. To access the replay, go to the InvestorRelations section of the website.

Dendreon Corporation is a biotechnology company whose mission is to targetcancer and transform lives through the discovery, development andcommercialization of novel therapeutics. The Company applies its expertise inantigen identification, engineering and cell processing to produce activecellular immunotherapy product candidates designed to stimulate an immuneresponse. Dendreon is also developing an orally-available small molecule thattargets Trp-p8 that could be applicable to multiple types of cancer as well asbenign prostatic hyperplasia. The Company has its headquarters in Seattle,Washington and is traded on the Nasdaq Global Market under the symbol DNDN.For more information about the Company and its programs, visit

SOURCE Dendreon Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Chindex International, Inc. to Participate in UBS ...
Neurobiological Technologies Reports Receipt of $1...